Menu
Menu
Zydus Lifesciences has secured USFDA approval for its Lidocaine and Prilocaine Cream, a topical anesthetic used for pain relief during minor procedures. With significant market potential and production set at their Ahmedabad facility, this approval strengthens Zydus' position in the competitive U.S. generics market.
Glenmark Pharmaceuticals has launched its Lacosamide Oral Solution, a bioequivalent to Vimpat® Oral Solution, offering a more affordable treatment option for partial-onset seizures. This new product enhances access to epilepsy care, with the same therapeutic efficacy as the branded version, making it a valuable option for patients and healthcare providers.